Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer

por Haseltine, Justin M., Offin, Michael, Flynn, Jessica R., Zhang, Zhigang, Lebow, Emily S., Aziz, Khaled, Makhnin, Alex, Eichholz, Jordan, Lim, Lee P., Li, Mark, Isbell, James M., Gomez, Daniel R., Li, Bob T., Rimner, Andreas
Publicado 2022

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

por Poels, Kamrine E., Schoenfeld, Adam J., Makhnin, Alex, Tobi, Yosef, Wang, Yuli, Frisco-Cabanos, Heidie, Chakrabarti, Shaon, Shi, Manli, Napoli, Chelsi, McDonald, Thomas O., Tan, Weiwei, Hata, Aaron, Weinrich, Scott L., Yu, Helena A., Michor, Franziska
Publicado 2021

Author Correction: Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

por Poels, Kamrine E., Schoenfeld, Adam J., Makhnin, Alex, Tobi, Yosef, Wang, Yuli, Frisco-Cabanos, Heidie, Chakrabarti, Shaon, Shi, Manli, Napoli, Chelsi, McDonald, Thomas O., Tan, Weiwei, Hata, Aaron, Weinrich, Scott L., Yu, Helena A., Michor, Franziska
Publicado 2022